Alignment Health’s Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen

Alignment Health's 2026 survey reveals that 90% of seniors face at least one social barrier to healthy aging, with aging-in-place challenges, healthcare access issues, and economic instability as top concerns. The study shows worsening trends year-over-year, including increased difficulty maintaining independence and rising medical debt. Over one-quarter of seniors skipped needed medical care, with 34% citing aging-in-place challenges as the reason.

09/10/2026, 8:00 AM • GlobeNewswire

Alignment Health Plan and Hoag Health System Increase Access to Award-Winning Care for Orange County Seniors

Alignment Health Plan announced an expanded partnership with Hoag Health System effective January 1, 2027, providing Medicare Advantage members in Orange County with in-network access to Hoag's physicians, hospitals, specialty programs, and urgent care facilities. The collaboration aims to improve healthcare access and affordability for seniors by combining Alignment's care model with Hoag's extensive local provider network.

09/08/2026, 11:00 AM • GlobeNewswire

Kaplan Fox is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) and Certain of its Officers and Directors for Potential Securities Law Violations

Law firm Kaplan Fox is investigating Alignment Healthcare (ALHC) for potential securities violations following a whistleblower complaint alleging accounting irregularities and misclassification of operating expenses as capital expenditures. The allegations artificially inflated the company's financial results and Adjusted EBITDA metrics. ALHC stock fell 16.7% on July 8, 2026, following the news.

08/26/2026, 10:45 AM • GlobeNewswire

Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors with Significant Losses to Contact the Firm Before September 22, 2026

Kaplan Fox & Kilsheimer LLP has filed class action lawsuits against PROCEPT BioRobotics Corporation for allegedly using undisclosed discount programs that artificially inflated handpiece unit sales and revenues during the Class Period (February 28, 2024 - February 25, 2026). The firm is also pursuing cases against Hub Group, Inc. and investigating potential securities violations at Alignment Healthcare, Inc. Investors with losses are encouraged to contact the firm before respective deadlines.

08/07/2026, 10:45 AM • GlobeNewswire

Lowey Dannenberg, P.C. is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for Potential Violations of the Federal Securities Laws

Law firm Lowey Dannenberg is investigating Alignment Healthcare (ALHC) for potential federal securities violations following allegations by a former executive that the company manipulated finances by misclassifying $8-10 million in operating expenses as capital expenditures to artificially inflate adjusted EBITDA. The disclosure caused Alignment's stock to fall 16.7% on July 8, 2026.

08/04/2026, 3:44 PM • GlobeNewswire

Alignment Healthcare, Inc. Investigated by the Portnoy Law Firm

The Portnoy Law Firm has initiated an investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) for alleged securities fraud. A former chief transformation officer filed a whistleblower complaint claiming the company misclassified $8-10 million in operational costs as capital expenditures to artificially inflate adjusted EBITDA and boost share price. Following the disclosure on July 8, 2026, Alignment's stock dropped $4.02 per share (16.7%) to $20.03, harming shareholders.

07/30/2026, 9:45 AM • GlobeNewswire

Kaplan Fox Encourages Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to Learn More About the Investigation of Potential Securities Law Violations

Law firm Kaplan Fox is investigating Alignment Healthcare (ALHC) following a whistleblower complaint alleging accounting irregularities where millions in operating expenses were misclassified as capital expenditures, artificially inflating financial metrics including Adjusted EBITDA. The stock fell 16.7% on July 8, 2026, following the disclosure.

07/29/2026, 10:45 AM • GlobeNewswire

ALHC INVESTOR ALERT: HBSS Launches Investigation into Alignment Healthcare, Inc. (ALHC) Following Whistleblower Allegations of Financial Manipulation

Hagens Berman is investigating Alignment Healthcare, Inc. (ALHC) following whistleblower allegations that the company engaged in accounting irregularities by misclassifying operating expenses as capital expenditures to artificially inflate EBITDA and financial metrics. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.

07/28/2026, 12:55 PM • GlobeNewswire

Kaplan Fox Reminds Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) to Contact the Firm Regarding an Investigation of Potential Securities Law Violations

Law firm Kaplan Fox is investigating Alignment Healthcare for alleged accounting irregularities where millions in operating expenses were misclassified as capital expenditures, artificially inflating financial metrics including Adjusted EBITDA. The stock fell 16.7% on July 8, 2026, following the whistleblower complaint disclosure.

07/22/2026, 10:00 AM • GlobeNewswire

ALHC INVESTOR ALERT: HBSS Launches Investigation into Alignment Healthcare, Inc. (ALHC) Following Whistleblower Allegations of Financial Manipulation

Hagens Berman is investigating Alignment Healthcare (ALHC) following whistleblower allegations that the company engaged in accounting irregularities by misclassifying operating expenses as capital expenditures to inflate EBITDA and financial results for 2024-2025. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.

07/15/2026, 3:47 PM • GlobeNewswire

UNCY: Unicycive Therapeutics Investors with Losses Should Contact Block & Leviton About Securities Fraud Investigation

Block & Leviton is investigating Unicycive Therapeutics for potential securities law violations related to false or misleading statements about FDA review of its OLC New Drug Application. The company received a second Complete Response Letter on June 30, 2026, citing manufacturing deficiencies, which led to a stock price decline. Investors who have suffered losses are encouraged to contact the firm.

07/13/2026, 2:05 PM • GlobeNewswire

ALHC INVESTOR ALERT: HBSS Launches Investigation into Alignment Healthcare, Inc. (ALHC) Following Whistleblower Allegations of Financial Manipulation

Hagens Berman is investigating Alignment Healthcare (ALHC) following whistleblower allegations that the company engaged in accounting irregularities, misclassifying operating expenses as capital expenditures to inflate EBITDA and financial metrics. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.

07/08/2026, 9:20 PM • GlobeNewswire

ALHC ALERT: Block & Leviton Investigating Alignment Healthcare, Inc. For Possible Securities Fraud; Investors Should Contact Block & Leviton to Learn More

Block & Leviton is investigating Alignment Healthcare, Inc. (ALHC) for potential securities law violations following allegations that a former executive filed a whistleblower lawsuit claiming the company manipulated finances to boost stock price and executive compensation. The stock fell approximately 16.72% following the report. The firm is also investigating Jefferies Financial Group and Unicycive Therapeutics for similar violations.

07/08/2026, 5:47 PM • GlobeNewswire

ALHC Investor Notice: Johnson Fistel Investigates Alignment Healthcare, Inc.

Law firm Johnson Fistel announced an investigation into Alignment Healthcare (NASDAQ: ALHC) following a whistleblower lawsuit filed by a former executive alleging the company manipulated its finances to boost stock price and executive compensation. The firm is investigating whether the company complied with federal securities laws and is seeking investors who suffered losses.

07/08/2026, 3:42 PM • GlobeNewswire

Vice Chairman of Alignment Healthcare Sells 25,000 Shares. Does This Mean Sell ALHC?

Joseph Konowiecki, vice chairman of Alignment Healthcare, sold 25,000 shares on June 26 for $575,000, reducing his direct holdings by 2.2%. While the sale aligns with his historical trading pattern and occurs under a pre-filed trading plan, the timing coincides with his recent step down from chairman and follows a pattern of executive selling over the past year. However, insider sales are predictive of stock declines less than half the time, and investors should weigh this against other company fundamentals.

06/30/2026, 4:21 PM • The Motley Fool